1966181-14-5

Fonagepant Chemical Structure
1966181-14-5

Chemical Structure

Fonagepant

Synonym(s): FE 205030

  • CAS No.: 1966181-14-5
  • Formula:C66H88N16O16S2
  • Molecular Weight:1425.63

InChIKey: NDNYKUCHDRUVEM-YKOQRXGISA-N

SMILES: O=C1[C@@]2([H])N(C(CNC([C@@H](NC([C@@H](NC([C@@H](NC([C@H](CSSC[C@H](NC([C@@H](N1)CC3=CC=CC=C3)=O)C(N[C@H](C(N)=O)CC4=CN=CC=C4)=O)NC([C@@H](NC([C@@H](C(C)C)NC(C5=NC=CO5)=O)=O)CC6=C(C=CC=C6)C(N)=O)=O)=O)CCCNC(C)C)=O)CC(O)=O)=O)C(C)C)=O)=O)CCC2

Biological Activity: Fonagepant (FE 205030) is a calcitonin gene-related peptide (CGRP) receptor antagonist with an IC50 of 0.2 nM. Fonagepant selectively blocks CGRP receptor activity, inhibits CGRP-induced vasodilation, attenuates capsaicin-induced increase in skin blood flow, and blocks CGRP-induced vasodilation in isolated human mesenteric resistance arteries. Fonagepant can be used in studies related to acute migraine attacks[1].

Cat. No. Product Name Purity Description Pricing
HY-P12136
Fonagepant Fonagepant (FE 205030) is a calcitonin gene-related peptide (CGRP) receptor antagonist with an IC50 of 0.2 nM. Fonagepant selectively blocks CGRP receptor activity, inhibits CGRP-induced vasodilation, attenuates capsaicin-induced increase in skin blood flow, and blocks CGRP-induced vasodilation in isolated human mesenteric resistance arteries. Fonagepant can be used in studies related to acute migraine attacks.
Pricing 
Expand Hide
loading...
/
  • /
loading...
Size Price
Stock Quantity Availability Operate
/
In-stock
(Estimated to ship on )
(Estimated to ship TODAY)
Estimated to ship on
(Estimated to ship TODAY)

Amount:

USD 0.00

This product is a controlled substance and not for sale in your territory.

This product is not for sale in your territory.

This compound is listed in the SVHC (Substances of Very High Concern) candidate list of ECHA (European Chemicals Agency).

Pricing 
Expand Hide

References